legend

Innovation is the Key Benchmark, Focus on Four Healthcare Industry Sub-Sectors in 2023, Says Jafar Wang of Legend Capital

HONG KONG, Feb 15, 2023 – (ACN Newswire via SEAPRWire.com) – Legend Capital invested in 29 healthcare companies that officially disclosed financing rounds in 2022, according to the VBDATA Database. Since 2007, Legend Capital has continuously invested in healthcare across industry sub-sectors including innovative drugs, biotechnology, medical devices, diagnostic technology, professional services and supply chain.... » read more

Legend Capital Portfolio Company Bespin Global Completes USD100m Series D Financing

HONG KONG, Dec 15, 2022 – (ACN Newswire via SEAPRWire.com) – Legend Capital Portfolio Company Bespin Global, a Korea-headquartered cloud services company, has recently completed its Series D round financing of USD100 million, which will be used mostly for acquisitions. Concurrent with the investment, the investor, e& Enterprise, a leading digital services provider in UAE... » read more

Led by Legend Capital, GS Biotech Completes Nearly CNY100 million Pre-A Round Financing

HONG KONG, Dec 9, 2022 – (ACN Newswire via SEAPRWire.com) – Recently, Zhongke Guosheng (Hangzhou) Technology Co., Ltd (hereinafter referred to as “GS Biotech”) officially announced the completion of its nearly CNY100 million pre-A round financing, led by Legend Capital. The proceeds will be mainly used for the capacity expansion of core pipeline products 5-hydroxymethylfurfural... » read more

Legend Capital Portfolio Company Atour Successfully Lists on Nasdaq

HONG KONG, Nov 13, 2022 – (ACN Newswire via SEAPRWire.com) – On the evening of November 11, Beijing time, Legend Capital portfolio company Atour Lifestyle Holdings Limited (“Atour”) was officially listed on the Nasdaq Stock Exchange in the United States. It has priced its initial public offering of 4,750,000 American Depositary Shares (“ADSs”) at US$11.0... » read more

Legend Capital Portfolio Company Giant Biogene Successfully Lists on the HKEX

HONG KONG, Nov 7, 2022 – (ACN Newswire via SEAPRWire.com) – On November 4, 2022, Legend Capital portfolio company Giant Biogene (2367.HK) was successfully listed on the main board of the Hong Kong Stock Exchange. The number of Giant Biogene’s offer shares under the global offering is 22,608,800 shares at an issue price of HK$24.3... » read more

Led by Legend Capital, ClinBrain Completes Nearly CNY200 million Series C Round

HONG KONG, Nov 1, 2022 – (ACN Newswire via SEAPRWire.com) – Recently, the healthcare big data leader ClinBrain completed the Series C round of financing of nearly CNY200 million, led by Legend Capital. This round of financing will facilitate ClinBrain to continuously deepen its expertise in the field of healthcare big data, explore the deep... » read more

Led by Legend Capital, Easy-Flow Raises Tens of Millions of CNY in Angel Round

HONG KONG, Nov 1, 2022 – (ACN Newswire via SEAPRWire.com) – Shanghai Easy-Flow (“Easy-Flow”) recently completed its Angel financing round by raising tens of millions of CNY, led by Legend Capital. The fresh capital will be used for the R&D of Easy-Flow’s peripheral intervention pipeline. Data shows that there are a large number of patients... » read more

Co-Led by Legend Capital, Top Gene Delivery Enterprise VectorBuilder Secures CNY410mn in Series C Round

HONG KONG, Oct 20, 2022 – (ACN Newswire via SEAPRWire.com) – VectorBuilder Biotechnology (Guangzhou) Co., Ltd. (hereinafter referred to as “VectorBuilder”), a top gene delivery enterprise, recently announced the completion of its Series C round with CNY410 million, co-led by Legend Capital. The proceeds will facilitate VectorBuilder in continuously promoting the upgrading and capacity expansion... » read more

GalaxySpace Completes a New Financing Round with Legend Capital Re-upped

HONG KONG, Sep 25, 2022 – (ACN Newswire via SEAPRWire.com) – GalaxySpace, a Chinese commercial aerospace company, recently completed its latest financing round with a post-investment valuation of approximately RMB11 billion. As an existing shareholder, Legend Capital continued to support the company by following up on this financing round. Legend Capital first invested in GalaxySpace... » read more

Leadrive Technology Completes Series C Financing, Legend Capital Re-upped

HONG KONG, Sep 25, 2022 – (ACN Newswire via SEAPRWire.com) – Leadrive Technology, a leading supplier of power semiconductor and motor control solutions for new energy vehicles, recently announced its completion of the series C financing. As the existing shareholder, Legend Capital continued to support this round of financing. This round of financing will be... » read more

Legend Capital: The Logic of Technology Investment Has Changed

HONG KONG, Sep 2, 2022 – (ACN Newswire via SEAPRWire.com) – Legend Capital recently announced that it made its 100th IPO following the listing of its AI medical portfolio company Lunit on the KOSDAQ market on 21 July 2022. In addition, Legend Capital’s CRO portfolio company R&G Pharmastudies was successfully listed on the ChiNext of... » read more

Pursued progress while ensuring stability and built up momentum, Legend Holdings realized revenue of RMB237,685 million in the first half of 2022

HONG KONG, Aug 31, 2022 – (ACN Newswire via SEAPRWire.com) – Legend Holdings Corporation (stock code: 3396.HK) announced today the unaudited condensed consolidated interim results for the six months ended June 30, 2022 (the “Reporting Period”). During the Reporting Period, the Company’s revenue was RMB237,685 million and the net profit attributable to equity holders of... » read more

Led by Legend Capital, Multi-omics-leading Enterprise APTBIO Closes Series B with Hundreds of Millions of CNY

HONG KONG, Aug 19, 2022 – (ACN Newswire via SEAPRWire.com) – Shanghai Applied Protein Technology Co., Ltd. (“APTBIO”), a leading enterprise focused on mass spectrometry-based multi-omics applied to precision medicine, recently announced the completion of its Series B with hundreds of millions of CNY, which is led by Legend Capital. The proceeds from this round... » read more

Legend Capital Portfolio: China-leading CRO Enterprise R&G Pharmastudies Listed on the ChiNext Market Successfully

HONG KONG, Aug 15, 2022 – (ACN Newswire via SEAPRWire.com) – On August 2, 2022, R&G Pharmastudies Co., Ltd. (stock code: 301333.SZ), a China-leading CRO enterprise invested by Legend Capital, was successfully listed on the ChiNext of Shenzhen Stock Exchange. R&G Pharmastudies publicly issued 15,000,000 shares at a price of RMB78.88 per share, and the... » read more

Legend Capital Super Antibiotic Portfolio Company: Scarce Enterprise MicuRx Pharmaceuticals is Listed on the STAR Market Successfully

HONG KONG, Aug 9, 2022 – (ACN Newswire via SEAPRWire.com) – On August 5, 2022, Legend Capital portfolio company MicuRx Pharmaceuticals, a scarce enterprise in super antibiotic, was successfully listed on the STAR Market. MicuRx Pharmaceuticals issued 130,000,000 shares this time, accounting for 19.84% of the total share capital after the issuance. The total amount... » read more

New Power to Legend Capital Carbon Neutral Investment Portfolio: Ruicycle Raises Over RMB 300 Million from Series B

HONG KONG, Aug 8, 2022 – (ACN Newswire via SEAPRWire.com) – Shenzhen Ruicycle Environmental Protection Technology Co., Ltd (also known as Hengchuang Ruineng), a battery recycling company, recently accomplished the B round of fundraising with over RMB 300 million, which is backed by Legend Capital. This round of fundraising will be mainly used to improve... » read more

Led by Legend Capital, The Leading Intelligent Special Robot Company AKA Robotics Completes Series A Financing

HONG KONG, Jul 28, 2022 – (ACN Newswire via SEAPRWire.com) – Shenzhen AKA Robotics Technology Co., LTD. (hereinafter referred to as “AKA Robotics”), a leading intelligent special robot company, recently completed its Series A financing round, which was led by Legend Capital. This round of funds will be used to invest in R&D and accelerate... » read more

GameFi on Fire: Dragon Crypto Gaming’s Dragon Crypto Argenti Token ($DCAR) and The Legend of Aurum Draconis

Sydney, Australia, July 22, 2022 – (SEAPRWire) – Dragon Crypto Gaming (DCG) initial dex offering (IDO) of Dragon Crypto Argenti ($DCAR), a utility token for its expanding GameFi ecosystem, will be open for registration on July 20th, 2022, with the IDO taking place on July 26th, 2022. DCG has partnered with Avalaunch, the leading platform for decentralized fundraising... » read more

Legend Capital Portfolio Company: The Global-Leading AI Medical Imaging Company Lunit Goes Public Successfully

HONG KONG, Jul 21, 2022 – (ACN Newswire via SEAPRWire.com) – On July 21st, 2022, Lunit, a leading global AI-based cancer solutions provider invested by Legend Capital, was successfully listed on the KOSDAQ market. Founded in 2013, Lunit successfully established itself as the world’s top-notch artificial intelligence technology solution provider, mainly focusing on developing medical... » read more

Co-led by Legend Capital, Huili Biotechnology Completes Series A Financing Round with Hundreds of Million RMB

HONG KONG, Jul 7, 2022 – (ACN Newswire via SEAPRWire.com) – Jiangsu Huili Biotechnology Co., Ltd (“Huili Bio”), a next-generation synthetic biology enzyme computational design platform, recently announced the completion of its Series A financing round with hundreds of million RMB. This financing round was co-led by Legend Capital and the fresh capital will be... » read more